Mounjaro and Your Blood Work: What You Need to Know

Last reviewed: July 17, 2026

Last updated: July 17, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

When you start tirzepatide injections, your body undergoes measurable metabolic changes that show up in blood work within weeks. Knowing what to expect from routine lab tests helps you track progress, spot potential issues early, and stay confident in your treatment journey.

How Tirzepatide Changes Your Blood Sugar and Insulin Levels

Tirzepatide works by activating two hormone pathways—GLP-1 and GIP receptors—that control blood glucose and insulin secretion. Clinical trials show fasting glucose levels typically drop 20–40 mg/dL within the first 8–12 weeks of steady-dose therapy. Your pancreas responds by releasing less insulin, which means both fasting and post-meal glucose readings improve, and insulin resistance markers decline.

The metric HbA1c—which measures average blood sugar over three months—usually decreases by 1.5–2.5 percentage points in people without diabetes and even more dramatically in those with type 2 diabetes. Fasting insulin often falls by 30–50% as your cells become more responsive to the hormone. These changes reflect genuine metabolic improvement, not just appetite suppression.

Lipid Panel Shifts: What Happens to Cholesterol and Triglycerides

Many people on tirzepatide see their triglyceride levels drop by 15–30%, especially if they started with elevated numbers. Total cholesterol and LDL cholesterol often decrease modestly as weight loss progresses and insulin sensitivity improves. HDL cholesterol—the protective kind—may rise slightly as your body composition shifts and inflammation decreases. These lipid changes typically emerge over 12–16 weeks and can persist or improve further with sustained therapy.

The PlexusDx Precision Peptide Genetic Test analyzes GLP1R, GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Liver and Kidney Function: Monitoring Safety During Treatment

Liver enzymes (AST, ALT) and kidney markers (creatinine, eGFR) should remain stable or improve on tirzepatide, as weight loss and reduced inflammation typically benefit organ function. Baseline liver and kidney testing before starting therapy establishes your personal reference range, then repeat tests at 8–12 weeks and quarterly thereafter help ensure no unexpected changes develop. People with existing liver or kidney disease need closer monitoring, and your prescribing provider will adjust frequency based on your risk profile.

Tirzepatide itself does not directly damage the liver or kidneys; rather, the metabolic improvements from weight loss—lower blood pressure, reduced glucose, less fatty liver infiltration—usually enhance these organ markers. If you notice yellowing of skin or eyes, persistent right-sided abdominal pain, or unusual fatigue, report these symptoms immediately to your care team, even if routine labs appear normal.

Pancreatic Enzymes and Kidney Stones: When to Request Specific Tests

GLP-1 receptor agonists like tirzepatide carry a theoretical risk of acute pancreatitis, though this remains rare in clinical practice. Some providers check amylase and lipase—enzymes released by the pancreas—at baseline and if patients develop sudden severe upper abdominal pain, nausea, or vomiting. Dehydration, a risk factor for both pancreatitis and kidney stones, can occur when appetite suppression reduces fluid intake, so drinking at least 2–3 liters of water daily is essential throughout therapy.

Tirzepatide may slightly increase uric acid levels in some individuals, which can elevate kidney stone risk in susceptible people. If you have a personal or family history of kidney stones or gout, mention this when starting therapy. Your provider may recommend baseline uric acid testing and ensure adequate hydration. Most patients tolerate tirzepatide without pancreatic or renal complications when they maintain proper fluid intake and receive appropriate monitoring.

Genetic Insights: Personalize Your Metabolic Response Prediction

The PlexusDx Precision Peptide Genetic Test analyzes GLP1R (rs6923761), and GIPR (rs1800437) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Genetic testing also reveals predispositions to metabolic complications—such as higher baseline triglycerides or insulin resistance—so your care team can prioritize which blood markers to monitor most closely. The Precision Peptide Genetic Test costs $99 as an add-on after your first month of treatment, integrating your genetic profile with your actual lab results to refine your personalized therapy plan.

When to Schedule Blood Tests and How Often to Retest

Baseline blood work—including fasting glucose, lipid panel, liver function, kidney function, and thyroid screening—should occur before starting tirzepatide. A repeat comprehensive panel at 8–12 weeks captures the initial metabolic shift as your dose stabilizes. After that, annual testing suffices for most stable patients, though quarterly labs may be warranted if you're adjusting doses, have chronic conditions, or take medications that interact with metabolic markers.

If you're tracking progress toward specific health goals—such as normalizing HbA1c if you have prediabetes or managing cholesterol for cardiovascular health—more frequent testing (every 6–8 weeks) can provide motivating data and help your provider fine-tune your treatment. PlexusDx patients receive guidance on recommended testing intervals during their initial consultation, and your clinical team coordinates with your primary care doctor to ensure seamless monitoring.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Will my blood sugar drop dangerously low on tirzepatide?

Tirzepatide lowers fasting and post-meal glucose by improving insulin secretion and sensitivity, but dangerous hypoglycemia is extremely rare unless you're also taking insulin or sulfonylurea diabetes medications. If you take other diabetes drugs, your provider will adjust those doses to prevent low blood sugar. Monitoring fasting glucose at home and reporting results helps your care team keep you safe.

Can tirzepatide cause permanent changes to my liver or kidneys?

No. Tirzepatide does not cause direct organ damage. In fact, weight loss and metabolic improvements from tirzepatide typically improve liver and kidney function over time. Baseline and follow-up blood work (AST, ALT, creatinine, eGFR) confirm these organs remain healthy throughout therapy. People with advanced liver or kidney disease need closer monitoring and may require dose adjustments.

How much does tirzepatide cost through PlexusDx, and is blood work covered?

PlexusDx's compounded Tirzepatide Injection is $289/mo month-to-month (or $249/mo on the 6-month plan)—a flat rate regardless of your dose level, so your dose may increase but your price won't. PlexusDx serves all 50 states with no insurance required or membership fee. Blood work itself is ordered through your primary care doctor or any local lab; PlexusDx helps coordinate recommendations for what tests to request and when.

Should I be concerned about pancreatitis based on my blood work?

Acute pancreatitis on GLP-1 therapy is rare and occurs in roughly 1 per 1,000 patients. Baseline and follow-up amylase or lipase tests are typically not needed unless you develop severe upper abdominal pain or nausea. Staying well-hydrated, eating small frequent meals, and reporting unusual abdominal symptoms immediately to your provider reduces risk and catches any issues early.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GLP1R, and GIPR) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Genetic Testing 101 What You Need To Know Before Getting Tested
• Mounjaro For High Blood Pressure
• What Genetic Factors Determine How Much Sleep You Need Each Night
• Hers Mounjaro

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.